Chen R H
Department of Cardiovascular and Thoracic Surgery, Texas Heart Institute, Houston, USA.
Ann Thorac Surg. 1996 Sep;62(3):910-4. doi: 10.1016/s0003-4975(96)00462-6.
The scientific rationale for avoiding the use of calcium-enriched cardioplegic solutions and calcium supplementation during cardioplegic induction and the early phase of reperfusion in open heart surgical procedures is reviewed. The role of the extracellular and intracellular free ionized calcium concentrations during ischemia and reperfusion is explored and the biochemical effects of ischemia on calcium fluxes, adenosine triphosphate levels, and mitochondrial function are discussed. The role of calcium in causing myocardial stunning and the biochemical basis of reperfusion injury are also addressed. Both prolonged ischemia and an increased concentration of Ca2+ during reperfusion have proved to be deleterious. I conclude on the basis of my review that there is no justification for the use of calcium chloride before and during the early phase of reperfusion and that hypocalcemic perfusion is an effective and easily controllable means of myocardial protection.
本文回顾了在心脏直视手术中,在心脏停搏诱导期和再灌注早期避免使用富含钙的心脏停搏液和补充钙剂的科学依据。探讨了缺血和再灌注期间细胞外和细胞内游离离子钙浓度的作用,并讨论了缺血对钙通量、三磷酸腺苷水平和线粒体功能的生化影响。还阐述了钙在引起心肌顿抑中的作用以及再灌注损伤的生化基础。事实证明,长时间缺血和再灌注期间Ca2+浓度升高都是有害的。基于我的综述,我得出结论,在再灌注早期之前和期间使用氯化钙是没有道理的,而低钙灌注是一种有效且易于控制的心肌保护手段。